Join Now

Yearly Archives: 2024

NUSANO TO PRESENT ISOTOPE PRODUCTION CAPABILITIES AND COMMERCIALIZATION PLANS AT 7TH THERANOSTICS WORLD CONGRESS

VALENCIA, Calif. – March 20, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, will present at the 7th Theranostics World Congress taking place March 22-24, 2024, in Santiago, Chile. Greg Moffitt, Nusano Director of Target Development, will provide an overview of the company’s proprietary radioisotope production platform on Sunday, March 24. […]

Posted in BioUtah News | Comments Off on NUSANO TO PRESENT ISOTOPE PRODUCTION CAPABILITIES AND COMMERCIALIZATION PLANS AT 7TH THERANOSTICS WORLD CONGRESS

Merit Medical Launches the Micro ACE™ Advanced Micro-Access System

Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases SOUTH JORDAN, Utah, March 19, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced commercial release of its US Food and Drug Administration (FDA)-cleared Micro ACE Advanced Micro-Access System. […]

Posted in BioUtah News | Comments Off on Merit Medical Launches the Micro ACE™ Advanced Micro-Access System

Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device

Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device

Renalytix’s Successful Completion of Upsized $12M Placing

Successful Completion of Upsized $12M Placing NEW YORK and SALT LAKE CITY, March 12, 2024 – Renalytix plc (NASDAQ: RNLX) (LSE: RENX) is pleased to announce that following its announcement earlier today regarding a proposed Placing of Ordinary Shares (the “Launch Announcement“), it has successfully placed 46,801,872 Ordinary Shares (the “Placing Shares“) with both UK and US institutional […]

Posted in BioUtah News | Comments Off on Renalytix’s Successful Completion of Upsized $12M Placing

Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test

The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers™ and licensed by the CDSCO for use in diagnostic procedures

Posted in BioUtah News | Tagged , | Comments Off on Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test

LARGE, REAL-WORLD STUDIES DEMONSTRATE CONTINUED EXCELLENT OUTCOMES FOR PATIENTS RECEIVING EDWARDS SAPIEN TAVR

LARGE, REAL-WORLD STUDIES DEMONSTRATE CONTINUED EXCELLENT OUTCOMES FOR PATIENTS RECEIVING EDWARDS SAPIEN TAVR

Posted in BioUtah News | Tagged | Comments Off on LARGE, REAL-WORLD STUDIES DEMONSTRATE CONTINUED EXCELLENT OUTCOMES FOR PATIENTS RECEIVING EDWARDS SAPIEN TAVR

NUSANO OPENS RADIOCHEMISTRY LABORATORY TO ADVANCE ISOTOPE COMMERCIALIZATION AND CUSTOMER COLLABORATION

LU-177 SHIPMENTS EXPECTED TO BEGIN EARLY 2025, FOLLOWED BY AC-225

Posted in BioUtah News | Tagged | Comments Off on NUSANO OPENS RADIOCHEMISTRY LABORATORY TO ADVANCE ISOTOPE COMMERCIALIZATION AND CUSTOMER COLLABORATION

Recursion Announces Plans to Open New Office in London

Appoints Michael Bronstein as Scientific Advisor and launches recruiting effort to fill the first 20 open roles across technology and biology, establishing a hub for world-class TechBio talent in the heart of King’s Cross neighborhood

Posted in BioUtah News | Tagged | Comments Off on Recursion Announces Plans to Open New Office in London

Nomi Health, CHG Healthcare Partner to Meet Growing Need for Streamlined Care for Underserved Communities

Partnership closes gaps in care for high-needs commercial, Medicaid and Medicare populations

Posted in BioUtah News | Tagged | Comments Off on Nomi Health, CHG Healthcare Partner to Meet Growing Need for Streamlined Care for Underserved Communities

Halia Therapeutics to Present at BIO-Europe Spring 2024 Conference

Presentation to be held on Tuesday, March 19, from 11:30 a.m. – 11:45 a.m. CET

Posted in BioUtah News | Tagged | Comments Off on Halia Therapeutics to Present at BIO-Europe Spring 2024 Conference

Fabric Genomics Partners with Intermountain Children’s Health to Enhance Precision Diagnosis of Infants and Children Using Whole Genome Sequencing from Broad Clinical Labs

Fabric Genomics Partners with Intermountain Children’s Health to Enhance Precision Diagnosis of Infants and Children

Posted in BioUtah News | Tagged | Comments Off on Fabric Genomics Partners with Intermountain Children’s Health to Enhance Precision Diagnosis of Infants and Children Using Whole Genome Sequencing from Broad Clinical Labs

KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)

Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk

Posted in BioUtah News | Tagged | Comments Off on KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)